Clinical and Translational Discovery (Oct 2024)

Epigenetic regulation of Epstein–Barr virus: From bench to bedside

  • Xiao Gao,
  • Hao‐Xu Yang,
  • Shu Cheng,
  • Hua‐Man Cai,
  • Jie Xiong,
  • Wei‐Li Zhao

DOI
https://doi.org/10.1002/ctd2.357
Journal volume & issue
Vol. 4, no. 5
pp. n/a – n/a

Abstract

Read online

Abstract Background Epstein–Barr virus (EBV) is a double‐stranded DNA herpesvirus and establishes life‐long infection in 95% of the world's populations. Main body EBV is critically involved in multiple diseases. Aberrant signaling pathways, immune escape, and metabolic reprogramming play essential roles in EBV‐mediated pathogenesis. However, the underlying mechanisms have not yet been fully elucidated. Here we reviewed recent advances on the epigenetic regulation of EBV pathogenesis, which may translate to potential therapeutic strategies in EBV‐associated diseases. Conclusion Growing evidence has suggested that viral infections reconstruct epigenome to modulate gene expression both in the host and the virus levels.

Keywords